MorphoSys Raises EUR 115 Million In Private Placement

Martinsried / Munich, Germany, Nov. 15, 2016 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced that it has raised gross proceeds of approximately EUR 115 million in a private placement via an accelerated book building transaction. MorphoSys issued 2,622,088 new shares from authorized capital to institutional investors in Europe and North America at a price of EUR 44.00 per share. The offering represents approximately 9.9% of the registered pre-transaction share capital and will bring the total number of registered shares after the issuance to 29,159,770. The new shares will be admitted to listing on the Frankfurt Stock Exchange following their issuance.

"We are very pleased to announce the successful completion of our placement which we believe reflects both the significant progress made at MorphoSys over the past years and the great confidence of investors in the potential of our pipeline," said Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG. "The funds we have raised will allow us to further develop our proprietary portfolio, for example taking our anti-CD19 antibody MOR208 into a pivotal phase 3 study in diffuse large B cell lymphoma (DLBCL), an indication with high medical need. The new funds significantly strengthen our ability to execute our strategy."

Jens Holstein, Chief Financial Officer of MorphoSys AG commented: "In response to the overall progress the company achieved in recent years and the further promise of our pipeline, we received strong inbound interest from international investors. The offering allows us to meet this demand, strengthening our financial position and enhancing trading liquidity. The funds raised will provide additional strategic flexibility as we continue to build the company to create long-term value for our shareholders."

Deutsche Bank and J.P. Morgan acted as Joint Bookrunners for the offering. Trout Capital, LLC acted as financial advisor to MorphoSys on the transaction.